Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts
Year of publication: |
2005
|
---|---|
Authors: | Philipson, Tomas J. ; Berndt, Ernst R. ; Gottschalk, Adrian H. B. ; Strobeck, Matthew W. |
Publisher: |
Cambridge, Mass. : National Bureau of Economic Research |
Subject: | USA / Food and Drug Administration | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Aufsichtsbehörde | Regulatory agency | Wirkungsanalyse | Impact assessment | Wohlfahrtsanalyse | Welfare analysis | USA | United States | Zulassung | Finanzierung | Beschleunigung |
-
Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process
Berndt, Ernst R., (2004)
-
Overdose : how excessive government regulation stifles pharmaceutical innovation
Epstein, Richard A., (2006)
-
Cost-benefit analysis of the FDA : the case of the prescription drug user fee acts
Philipson, Tomas J., (2008)
- More ...
-
Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process
Berndt, Ernst R., (2004)
-
Assessing the Safety and Efficacy of the FDA : The Case of the Prescription Drug User Fee Acts
Philipson, Tomas J., (2005)
-
Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
Berndt, Ernst R., (2005)
- More ...